These findings present the intriguing prospect of a positive feedback loop, whereby breast and prostate cancer cells disable this anti‐cancer mechanism to encourage further proliferation of cancer cells, greater production of TGF‐β, and further knockdown of osteocyte regulation. This evidence concerns the gene TGFB1 and prostate carcinoma.